Evidence map›Paper›PMID 23359703›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2013

Involvement of Toso in activation of monocytes, macrophages, and granulocytes.

Karl S Lang, Philipp A Lang, Andreas Meryk, Aleksandra A Pandyra, Louis-Martin Boucher, Vitaly I Pozdeev, Michael W Tusche, Joachim R Göthert, Jillian Haight, Andrew Wakeham and 17 more

Open access · bronzeAbstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 42 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
42citing papers in PubMed, 1 pooled it
3.8field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

42 citing papers in PubMed, 1 synthesis or guideline pooled it, 79 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Microorganisms · 2021
    Review
  20. Differences between Human and Mouse IgM Fc Receptor (FcµR).International journal of molecular sciences · 2021
    Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

27 authors at 11 institutions in 5 countries.

Karl S LangCampbell Family Institute for Breast Cancer Research, Ontario Cancer Institute, University Health Network, Toronto, ON, Canada M5G 2C1.
Philipp A Lang
Andreas Meryk
Aleksandra A Pandyra
Louis-Martin Boucher
Vitaly I Pozdeev
Michael W Tusche
Joachim R Göthert
Jillian Haight
Andrew Wakeham
Annick J You-Ten
David R McIlwain
Katja Merches
Vishal Khairnar
Mike Recher
Garry P Nolan
Yasumichi Hitoshi
Pauline Funkner
Alexander A Navarini
Admar Verschoor
Namir Shaabani
Nadine Honke
Linda Z Penn
Pamela S Ohashi
Dieter Häussinger
Kyeong-Hee Lee
Tak W Mak
University Health Network · CAUniversity of Duisburg-Essen · DEHeinrich Heine University Düsseldorf · DEOntario Institute for Cancer Research · CAHarvard University · USInstitute of Medical Microbiology and Hygiene · DEResearch Center Borstel - Leibniz Lung Center · DERigel (United States) · USStanford University · USUniversity Hospital of Zurich · CHUniversity of Tübingen · DE

Funding

Systems Biology CoreU19AI100627 · NIAID · SCRIPPS RESEARCH INSTITUTE, THE · PI ULEVITCH, RICHARD J · 2012 to 2021
$49.1M
CIHR 79434NIAID NIH HHS U19 AI100627
6 · The paper itself

Abstract

Rapid activation of immune responses is necessary for antibacterial defense, but excessive immune activation can result in life-threatening septic shock. Understanding how these processes are balanced may provide novel therapeutic potential in treating inflammatory disease. Fc receptors are crucial for innate immune activation. However, the role of the putative Fc receptor for IgM, known as Toso/Faim3, has to this point been unclear. In this study, we generated Toso-deficient mice and used them to uncover a critical regulatory function of Toso in innate immune activation. Development of innate immune cells was intact in the absence of Toso, but Toso-deficient neutrophils exhibited more reactive oxygen species production and reduced phagocytosis of pathogens compared with controls. Cytokine production was also decreased in Toso(-/-) mice compared with WT animals, rendering them resistant to septic shock induced by lipopolysaccharide. However, Toso(-/-) mice also displayed limited cytokine production after infection with the bacterium Listeria monocytogenes that was correlated with elevated presence of Listeria throughout the body. Accordingly, Toso(-/-) mice succumbed to infections of L. monocytogenes, whereas WT mice successfully eliminated the infection. Taken together, our data reveal Toso to be a unique regulator of innate immune responses during bacterial infection and septic shock.

Indexed as

Analysis of VarianceAnimalsCarrier ProteinsCrosses, GeneticCytokinesEnzyme-Linked Immunosorbent AssayFlow CytometryGranulocytesImmunity, InnateImmunoblottingListeriosisMacrophage ActivationMembrane ProteinsMiceMice, KnockoutMonocytesCarrier ProteinsCytokinesFcmr protein, mouseMembrane ProteinsPeroxidaseReactive Oxygen Species

Identifiers

PMID23359703
PMCPMC3574925
OpenAlexW1999072281

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.